Lumos Diagnostics Holdings Restricted (LDXHF) This fall 2025 Earnings Name Transcript

George Kopsiaftis

Hi there everybody, welcome to the Lumos Diagnostics’ FY ’25 outcomes investor briefing. My identify is George Kopsiaftis, and I will be your moderator for at the moment. The webinar is being recorded at the moment and might be made out there on the Lumos web site over the following couple of days.

With us this morning, we have now Lumos Diagnostics’ CEO, Doug Ward. We have now CFO, Barrie Lambert, Paul Kase is the Senior Vice President of Business Operations; and Annie Bell, is our Vice President of Medical Affairs. Good morning to you all.

Barrie Lambert
Chief Monetary Officer

Good morning, George.

George Kopsiaftis

So the format for at the moment is for the group to stroll you thru the presentation that was launched to the ASX this morning. The presentation ought to take round 30 to 35 minutes. And this may then be adopted by a question-and-answer session. [Operator Instructions] That concludes housekeeping for at the moment. So I would wish to now hand it over to Doug to get us began. Thanks, Doug.

Douglas Ward
CEO, MD & Director

Thanks very a lot, George. Hi there, everybody. Actually happy to be with you at the moment to undergo our year-end 2025 financials, and various different updates that we have had and bulletins that we have remodeled the previous couple of weeks.

This, fairly frankly, I feel, is likely one of the most constructive webinars that we have needed to date. And we’re actually excited to usher in this at the moment, and I am actually happy to have each Paul and Annie with us given among the element in regard to gross sales as properly